⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| L-Fucose SCHEMBL16703726 | 1.00 | — | — | |
| L-Fucose SCHEMBL14830475 | 1.00 | — | — | |
| L-Fucose SCHEMBL5072536 | 1.00 | — | — | |
| L-Fucose SCHEMBL25051 | 1.00 | — | — | |
| L-Fucose SCHEMBL3462756 | 1.00 | — | — | |
| L-Fucose SCHEMBL466429 | 1.00 | — | — | |
| L-Fucose SCHEMBL2597764 | 1.00 | — | — | |
| L-Fucose SCHEMBL1746724 | 1.00 | — | — | |
| L-Fucose SCHEMBL11347428 | 1.00 | — | — | |
| L-Fucose SCHEMBL1458729 | 1.00 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 30 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3371206-B1 | METHODS OF MAKING FUCOSYLATED AND AFUCOSYLATED FORMS OF A PROTEIN | HOFFMANN LA ROCHE (CH) | 2021-04-14 | — | — | EP | claimed |
| EP-1664352-B1 | SEPARATION OF SUGARS | DUPONT NUTRITION BIOSCI APS (DK) | 2015-12-30 | — | — | EP | claimed |
| EP-2978857-A2 | RECOMBINANT PHAGE AND BACTERIAL DETECTION METHODS | Sample Technologies, Inc. (US) | 2016-02-03 | — | — | EP | disclosed |
| CN-105087556-A | Primer, kit and method for detecting poppy shell components based on LAMP technology | CHEN DINGHU | 2015-11-25 | — | — | CN | disclosed |
| WO-2015172082-A1 | CODON-OPTIMIZED RECOMBINANT PHAGE AND METHODS OF USING SAME | SAMPLE6 TECHNOLOGIES, INC. (US) | 2015-11-12 | — | — | WO | disclosed |
| WO-2014160818-A2 | RECOMBINANT PHAGE AND BACTERIAL DETECTION METHODS | SAMPLE TECHNOLOGIES, INC. (US) | 2014-10-02 | — | — | WO | disclosed |
| EP-2760477-A1 | DI-ALIPHATIC SUBSTITUTED PEGYLATED LIPIDS | Alnylam Pharmaceuticals, Inc. (US) | 2014-08-06 | — | — | EP | disclosed |
| CN-103319282-B | Disease and insect resistant fertilizer produced by traditional Chinese medicines and preparation technology thereof | WEI WENLI | 2014-08-06 | — | — | CN | disclosed |
| WO-2013049328-A9 | DI-ALIPHATIC SUBSTITUTED PEGYLATED LIPIDS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2013-12-27 | — | — | WO | disclosed |
| EP-2663548-A1 | PEGYLATED LIPIDS AND THEIR USE FOR DRUG DELIVERY | Alnylam Pharmaceuticals, Inc. (US) | 2013-11-20 | — | — | EP | disclosed |
| CN-103319282-A | Disease and insect resistant fertilizer produced by traditional Chinese medicines and preparation technology thereof | WEI WENLI | 2013-09-25 | — | — | CN | disclosed |
| WO-2011094580-A2 | CHELATED COPPER FOR USE IN THE PREPARATION OF CONJUGATED OLIGONUCLEOTIDES | ALNYLAM PHARMACEUTICALS, INC. (US) | 2011-08-04 | — | — | WO | disclosed |
| WO-2011075656-A1 | METHODS AND COMPOSITIONS FOR DELIVERY OF NUCLEIC ACIDS | THE UNIVERSITY OF BRITISH COLUMBIA (CA) | 2011-06-23 | — | — | WO | disclosed |
| WO-2009142822-A9 | 2-F MODIFIED RNA INTERFERENCE AGENTS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2010-01-14 | — | — | WO | disclosed |
| WO-2010006237-A2 | PHOSPHOROTHIOATE OLIGONUCLEOTIDES NON-NUCLEOSIDIC PHOSPHOROTHIOTES AS DELIVERY AGENTS FOR IRNA AGENTS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2010-01-14 | — | — | WO | disclosed |
| WO-2009142822-A2 | 2-F MODIFIED RNA INTERFERENCE AGENTS | ALNYLAM PHARMACEUTICALS, INC. (US) | 2009-11-26 | — | — | WO | disclosed |
| EP-1625138-A2 | PROTECTED MONOMERS | Alnylam Pharmaceuticals Inc. (US) | 2006-02-15 | — | — | EP | disclosed |
| EP-1615611-A2 | iRNA CONJUGATES | Alnylam Pharmaceuticals Inc. (US) | 2006-01-18 | — | — | EP | disclosed |
| WO-2004094345-A2 | PROTECTED MONOMERS | ALNYLAM PHARMACEUTICALS INC. (US) | 2004-11-04 | — | — | WO | disclosed |
| WO-2004091515-A2 | iRNA CONJUGATES | ALNYLAM PHARMACEUTICALS, INC. (US) | 2004-10-28 | — | — | WO | disclosed |